Select Page

Commonwealth Views

© Commonwealth Secretariat

Canada approves first generic version of Ozempic amid rising GLP-1 competition

Canada approves first generic version of Ozempic amid rising GLP-1 competition

Health Canada has approved the first generic version of Novo Nordisk’s diabetes drug Ozempic in Canada, with Dr Reddy’s Laboratories set to market the copycat treatment. The decision comes as several drugmakers move to challenge the blockbuster GLP-1 drug with lower-cost alternatives. The approval could test how generics compete with branded peptide drugs in Canada, where pricing is often far...